Leading UK contract development and manufacturing organisation (CDMO) Upperton Pharma Solutions, has completed the build of its new sterile manufacturing facility in Nottingham, UK. The new facility ...
07 JAN 2026: Sharp Sterile Manufacturing has today announced a $28 million expansion of its site in Lee, Massachusetts. The enhanced state-of-the-art facility will strengthen opportunities for highly ...
CMO's Nottingham site first to use EmulTech's ET4ME technology for GMP production of pharmaceuticals Newcastle and Eindhoven, 18 February, 2013: Aesica, the global contract manufacturing organisation ...
PARSIPPANY, N.J., Oct. 27, 2025 /PRNewswire/ -- Simtra BioPharma Solutions, a leading contract development and manufacturing organization (CDMO) specializing in sterile injectables, is making progress ...
Explore how parenteral manufacturing solutions are evolving for specific drug formulations and meeting the demands of advanced therapies.
DPT Laboratories defines newly-expanded sterile pharmaceutical manufacturing capabilities at its Center of Excellence in Lakewood, N.J. LAKEWOOD, N.J.--(BUSINESS WIRE)--DPT Laboratories, Ltd., a ...
Delhi, India--(Newsfile Corp. - August 21, 2025) - Akums Drugs & Pharmaceuticals Ltd., India's largest contract development and manufacturing organization (CDMO), proudly announces that its Sterile ...
BEDFORD, N.H., June 17, 2019 /PRNewswire/ — Lyophilization Services of New England (LSNE), a leading contract development and manufacturing organization (CDMO), announced today the acquisition of a ...
Somerset, NJ, June 5, 2012 — Catalent Pharma Solutions announced today the completion of the construction of its newly renovated 3,300 square foot aseptic fill-finish manufacturing facility at ...
Evotec AG has announced the expansion of its sterile pharmaceutical manufacturing facility in Glasgow, Scotland. The Company has doubled its capacity for the aseptic (sterile) GMP manufacture of ...
[12/13/2013] The U.S. Food and Drug Administration is alerting health care providers, hospital supply managers, and pharmacists that 2 to 3 millimeter, irregularly shaped floating matter was observed ...
Advancing U.S.-based cGMP manufacturing to support clinical and future commercial objectives of a novel siRNA therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results